Prenatal Exposure to Chemical Mixtures and Metabolic Syndrome Risk in Children.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 May 2024
Historique:
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 23 5 2024
Statut: epublish

Résumé

Prenatal exposure to ubiquitous endocrine-disrupting chemicals (EDCs) may increase the risk of metabolic syndrome (MetS) in children, but few studies have studied chemical mixtures or explored underlying protein and metabolic signatures. To investigate associations of prenatal exposure to EDC mixtures with MetS risk score in children and identify associated proteins and metabolites. This population-based, birth cohort study used data collected between April 1, 2003, and February 26, 2016, from the Human Early Life Exposome cohort based in France, Greece, Lithuania, Norway, Spain, and the UK. Eligible participants included mother-child pairs with measured prenatal EDC exposures and complete data on childhood MetS risk factors, proteins, and metabolites. Data were analyzed between October 2022 and July 2023. Nine metals, 3 organochlorine pesticides, 5 polychlorinated biphenyls, 2 polybrominated diphenyl ethers (PBDEs), 5 perfluoroalkyl substances (PFAS), 10 phthalate metabolites, 3 phenols, 4 parabens, and 4 organophosphate pesticide metabolites measured in urine and blood samples collected during pregnancy. At 6 to 11 years of age, a composite MetS risk score was constructed using z scores of waist circumference, systolic and diastolic blood pressures, triglycerides, high-density lipoprotein cholesterol, and insulin levels. Childhood levels of 44 urinary metabolites, 177 serum metabolites, and 35 plasma proteins were quantified using targeted methods. Associations were assessed using bayesian weighted quantile sum regressions applied to mixtures for each chemical group. The study included 1134 mothers (mean [SD] age at birth, 30.7 [4.9] years) and their children (mean [SD] age, 7.8 [1.5] years; 617 male children [54.4%] and 517 female children [45.6%]; mean [SD] MetS risk score, -0.1 [2.3]). MetS score increased per 1-quartile increase of the mixture for metals (β = 0.44; 95% credible interval [CrI], 0.30 to 0.59), organochlorine pesticides (β = 0.22; 95% CrI, 0.15 to 0.29), PBDEs (β = 0.17; 95% CrI, 0.06 to 0.27), and PFAS (β = 0.19; 95% CrI, 0.14 to 0.24). High-molecular weight phthalate mixtures (β = -0.07; 95% CrI, -0.10 to -0.04) and low-molecular weight phthalate mixtures (β = -0.13; 95% CrI, -0.18 to -0.08) were associated with a decreased MetS score. Most EDC mixtures were associated with elevated proinflammatory proteins, amino acids, and altered glycerophospholipids, which in turn were associated with increased MetS score. This cohort study suggests that prenatal exposure to EDC mixtures may be associated with adverse metabolic health in children. Given the pervasive nature of EDCs and the increase in MetS, these findings hold substantial public health implications.

Identifiants

pubmed: 38780942
pii: 2819044
doi: 10.1001/jamanetworkopen.2024.12040
doi:

Substances chimiques

Endocrine Disruptors 0
Environmental Pollutants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2412040

Auteurs

Nuria Güil-Oumrait (N)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Pompeu Fabra University, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Nikos Stratakis (N)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Léa Maitre (L)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Pompeu Fabra University, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Augusto Anguita-Ruiz (A)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Pompeu Fabra University, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Jose Urquiza (J)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Lorenzo Fabbri (L)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Pompeu Fabra University, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Xavier Basagaña (X)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Pompeu Fabra University, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Barbara Heude (B)

Université Paris Cité and Université Sorbonne Paris Nord, National Institute of Health and Medical Research (INSERM), National Institute for Agriculture, Food and the Environment (INRAE), Center for Research in Epidemiology and StatisticS (CRESS), Paris, France.

Line Småstuen Haug (LS)

Department of Food Safety, Norwegian Institute of Public Health, Oslo, Norway.

Amrit Kaur Sakhi (AK)

Department of Food Safety, Norwegian Institute of Public Health, Oslo, Norway.

Nina Iszatt (N)

Division of Climate and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.

Hector C Keun (HC)

Cancer Metabolism & Systems Toxicology Group, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom.

John Wright (J)

Bradford Institute for Health Research, Bradford Teaching Hospitals National Health Service Foundation Trust, Bradford, United Kingdom.

Leda Chatzi (L)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles.

Marina Vafeiadi (M)

Department of Social Medicine, University of Crete, Heraklion, Crete, Greece.

Mariona Bustamante (M)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Pompeu Fabra University, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Regina Grazuleviciene (R)

Department of Environmental Sciences, Vytautas Magnus University, Kaunas, Lithuania.

Sandra Andrušaityte (S)

Department of Environmental Sciences, Vytautas Magnus University, Kaunas, Lithuania.

Rémy Slama (R)

Department of Prevention and Treatment of Chronic Diseases, Institute for Advanced Biosciences (IAB; INSERM U1209, CNRS UMR 5309), Université Grenoble Alpes, Grenoble, France.

Rosemary McEachan (R)

Bradford Institute for Health Research, Bradford Teaching Hospitals National Health Service Foundation Trust, Bradford, United Kingdom.

Maribel Casas (M)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Pompeu Fabra University, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Martine Vrijheid (M)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Pompeu Fabra University, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH